Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Role of amino-acid PET in high-grade gliomas: limitations and perspectives

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Innovations in PET/CT

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Technological innovations in nuclear medicine imaging

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. FDG-PET/CT for detection of the unknown primary head and neck tumor

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. PET imaging of meningioma with 18F-FLT: a predictor of tumour progression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effect of blood glucose and body weight on image quality in brain [18F]FDG PET imaging

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Positron emission tomography (PET) using radiolabeled amino-acids was recently recommended by the Response Assessment in Neuro-Oncology (RANO) working group as an additional tool in the diagnostic assessment of brain tumors. The aim of this review is to summarize available literature data on the role of amino-acid PET imaging in high-grade gliomas (HGGs), with regard to diagnosis, treatment planning and follow-up of these tumors. Indeed, amino-acid PET applications are multiple throughout the evolution of HGGs. However, certain limitations such as lack of specificity, uncertain value for grading and prognostication or the limited data for treatment monitoring should to be taken into account, the latter of which are further developed in this review. Notwithstanding these limitations, amino-acid PET is becoming increasingly accessible in many nuclear medicine centers. Larger prospective cohort prospective studies are thus needed in order to increase the clinical value of this modality and enable its extended use to the largest number of patients.

OriginalsprogEngelsk
TidsskriftQuarterly Journal of Nuclear Medicine and Molecular Imaging
Vol/bind62
Udgave nummer3
Sider (fra-til)254-266
Antal sider13
ISSN1824-4785
DOI
StatusUdgivet - sep. 2018

ID: 56525181